RxDoctor Payments Data

Mayra Torres Brink, PA

Physician Assistant · Monmouth, MENPI 1427399906

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,146in general payments, 2019–2025

Across 344 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Galderma Laboratories, L.p.$765
  • UCB, Inc.$694
  • Regeneron Healthcare Solutions, Inc.$453
  • Lilly USA, LLC$411
  • E.r. Squibb & Sons, L.L.C.$398
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$5,86295%
  • Education$2855%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,146 in reported general payments places this provider in the 95th percentile of 774 physician assistant providers in Maine.

See all physician assistant providers in Maine

Medicare billing

Part B allowed, 2024
$29,670
Medicare patients
162
Services billed
815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$22,610
Tacrolimus22$4,319
Fluorouracil13$1,020
Levothyroxine Sodium76$1,007
Rosuvastatin Calcium34$989
Albuterol Sulfate HfaAlbuterol Sulfate18$970
Atorvastatin Calcium78$876
Clobetasol Propionate32$867
Gabapentin27$824
Ketoconazole41$794
Amitriptyline Hcl17$718
Omeprazole41$664
Clindamycin Phosphate17$660
Triamcinolone Acetonide41$612
Metoprolol Succinate29$470

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$273$22,61023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 774 physician assistant providers in Maine.

Other physician assistant in Monmouth

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →